Top Menu

Home
About
Contact Us

Navigation

DTC Perspectives Pharmaceutical Marketing Conference Leaders

Home

Main

Events
Speak
Awards
- Nominate/Submit
- Winners
Contribute
Services
Advertise
- Advertising Opportunities
- Sponsored Content
Become an Author
- Author SignIn
- Author SignUp
Ehrlich on Creative

Return to Content

Bob Ehrlich

By admin on June 25, 2015 in

Sanders Blasts Drug Companies

No comments yet.

Leave a Reply Click here to cancel reply.

Comment *

Name (required)

Email (will not be published) (required)

Website

Δ

Subscribe / Connect

Subscribe to our e-mail newsletter to receive updates.

For Email Newsletters you can trust.

Latest
Popular

Digital disruption is transforming the online world—here’s how to keep reaching patients January 16, 2024
2024 Direct-to-Consumer Pharmaceutical Marketing Trends: A Strategic Blueprint January 5, 2024
Bridging the Gap: Marketing New-Age Mental Health Treatments to Diverse Audiences December 4, 2023
Femtech: Changing the Game in Women’s Health Care November 8, 2023
Bringing Diversity to Clinical Trials: An Essential Step for Better Healthcare November 7, 2023

Creative Critique: OPDIVO & BELSOMRA October 28, 2015
Increasing Medication Adherence with Multi-Channel Communications July 20, 2016
Print: Alive and Well at the Point of Care May 19, 2016
DTC in Perspective: Entresto Is Interesto! May 13, 2016
DTC in Perspective: The Media Bias Against DTC November 16, 2015

Subscribe / Connect

Subscribe to our e-mail newsletter to receive updates.

© 2024 DTC Perspectives. All Rights Reserved.